LONDON – The search for modulators of the immune cascade that is the cause of the most severe respiratory symptoms of COVID-19 is intensifying, with Cyclacel Pharmaceuticals Inc. and Pharming Group NV adding their drugs to the list of repurposing projects. Leiden, Netherlands-based Pharming is planning a 150-patient trial of its C1 inhibitor Ruconest after seeing encouraging results in a compassionate […]

As COVID-19 continues to spread, many of us have become as conscious as ever when it comes to cleaning. Whether it’s wiping countertops, disinfecting belongings we frequently touch, washing our hands or wearing face masks, it may feel unusual and sometimes exhausting. For those who live with Obsessive-Compulsive Disorder (OCD), the changes in daily life […]

Three companies announced COVID-19 programs Monday aimed at blocking the excessive inflammatory response seen in severe cases. Alexion unveiled a global program for its C5 inhibitor Ultomiris, while 4D pharma moved its live biotherapeutic therapy closer to the clinic, and Cyclacel partnered with the University of Edinburgh to test its pair of apoptosis regulators. The […]